Inhibition of Human Neutrophil Functions In Vitro by Multiple Sclerosis Disease-Modifying Therapies

There is a growing optimism about the potential of new disease-modifying therapies (DMTs) in the management of relapsing-remitting multiple sclerosis (RRMS) patients. However, this initial enthusiasm has been tempered by evidence indicating that multiple sclerosis (MS) patients undergoing DMT may be...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Med
Autori principali: Scutera, Sara, Musso, Tiziana, Cavalla, Paola, Piersigilli, Giorgia, Sparti, Rosaria, Comini, Sara, Vercellino, Marco, Cuffini, Anna Maria, Banche, Giuliana, Allizond, Valeria
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7692529/
https://ncbi.nlm.nih.gov/pubmed/33147889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113542
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi